GLP-1 Agonists: Exciting Tools with Real Challenges
GLP-1 receptor agonists like semaglutide and tirzepatide are changing the conversation around weight management and blood sugar control. But with their rise in popularity comes a new wave of patient challenges—from cost and access to side effects and misinformation. In this post, we dig into the real-world barriers patients face on GLP-1s and how clinicians can support them, based on a candid (and chaotic) dinner-table conversation that might sound a lot like your own.